Cerebral Near Infrared Spectroscopy in Out-of-Hospital Cardiac Arrest and Neurological Prognosis
NISOHCA
2 other identifiers
interventional
542
1 country
6
Brief Summary
Out-of-hospital cardiac arrest (OHCA) prognosis remains poor : 7% of patients surviving without neurological impairment. 65% of patients dying after hospital admission were neurologically impaired. When treating a patient with CA, neurological outcome remains extremely difficult to predict, especially in the pre-hospital setting. Practitioners have very little objective information to help them with neuropronostication. Although an EtCO2 level of \< 10 mmHg is associated with a poor neurological prognosis, European recommendations point out that this data alone is not currently sufficient to predict a patient's prognosis or to make a decision to stop resuscitation. Current recommendations do not suggest any other objective parameter during resuscitation for neuropronostication of patients with out-of-hospital cardiac arrest. Cerebral tissue oxygen saturation (rSO2) is measured using the near infrared spectrometry (NIRS) technique. Cerebral NIRS (cNIRS) enables non-invasive measurement of changes in cerebral oximetry during the management of a cardiac arrest (CA). Various clinical studies conducted over the last ten years have demonstrated that there is a probable link between cNIRS levels during resuscitation and return of spontaneous circulation (ROSC), but a clear threshold value has not been defined. The aim of the NISOHCA study is to confirm that a 40% threshold of cNIRS in the pre-hospital setting for OHCA can specifically predict survival with good neurological outcome at D90 .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2025
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2025
CompletedFirst Posted
Study publicly available on registry
May 15, 2025
CompletedStudy Start
First participant enrolled
November 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
May 15, 2025
May 1, 2025
2.3 years
April 17, 2025
May 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cerebral Performance Category (CPC)
Specificity of predicting a 90-D survival with a good neurological outcome with a mean c-NIRS \> 40% during Cardiopulmonary Resuscitation (CPR). Cerebral Performance Category (CPC) of 1 to 5. CPC 1: Complete recovery without neurological impairment or conscious with minor impairment. CPC 5: Deceased or brain dead.
Day 90
Secondary Outcomes (7)
Cerebral Performance Category (CPC)
Day 90
Cerebral Performance Category (CPC) after Return of Spontaneous Circulation(ROSC)
Day 90
Return of Spontaneous Circulation
1 hour
The cumulative dose of adrenaline.
During out-of-hospital cardiopulmonary resuscitation.
Resuscitation duration.
During out-of-hospital cardiopulmonary resuscitation.
- +2 more secondary outcomes
Study Arms (1)
Cerebral Near infrared spectroscopy (NIRSc) group
EXPERIMENTALThe use of cerebral Near infrared spectroscopy to predict the neurological prognosis of patients treated for out-of-hospital cardiac arrest.
Interventions
Continuous cerebral near-infrared spectroscopy (NIRSc) during resuscitation in a patient treated for out-of-hospital cardiac arrest (OHCA).
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Non-traumatic out-of-hospital cardiac arrest witnessed and managed by the mobile emergency unit (SMUR).
You may not qualify if:
- Scalp/cranial or facial injury preventing the placement of electrodes for NIRS measurement.
- Spontaneous cardiac activity upon the arrival of the SMUR.
- Decision by the SMUR physician not to initiate specialized resuscitation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
CH Colmar- Urgences - SAMU-SMUR
Colmar, 68000, France
CHR Metz-Thionville - Mercy hospital -Urgences - SAMU-SMUR
Metz, 5700, France
CHRU NANCY - urgences SAMUR SMUR- Central hospital
Nancy, 54000, France
CHU Reims - ugences - SAMU-SMUR
Reims, 51100, France
Hôpitaux universitaire de Strasbourg - Urgences - SAMU-SMUR
Strasbourg, 67200, France
CHR Troyes- Urgences - SAMU-SMUR
Troyes, 10000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nicolas GIRERD, MD-PhD
CHRU de NANCY
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinating Investigator
Study Record Dates
First Submitted
April 17, 2025
First Posted
May 15, 2025
Study Start
November 1, 2025
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Last Updated
May 15, 2025
Record last verified: 2025-05